Steven Shallcross

2017

In 2017, Steven Shallcross earned a total compensation of $798.9K as Interim Chief Executive Officer and Chief Financial Officer at Synthetic Biologics, a 13% decrease compared to previous year.

Compensation breakdown

Bonus$200,000
Option Awards$177,746
Salary$346,500
Other$74,644
Total$798,890

Shallcross received $346.5K in salary, accounting for 43% of the total pay in 2017.

Shallcross also received $200K in bonus, $177.7K in option awards and $74.6K in other compensation.

Rankings

In 2017, Steven Shallcross' compensation ranked 10,039th out of 14,666 executives tracked by ExecPay. In other words, Shallcross earned more than 31.5% of executives.

ClassificationRankingPercentile
All
10,039
out of 14,666
32nd
Division
Manufacturing
3,879
out of 5,772
33rd
Major group
Chemicals And Allied Products
1,357
out of 2,075
35th
Industry group
Drugs
1,101
out of 1,731
36th
Industry
Pharmaceutical Preparations
862
out of 1,333
35th
Source: SEC filing on August 13, 2018.

Shallcross' colleagues

We found two more compensation records of executives who worked with Steven Shallcross at Synthetic Biologics in 2017.

2017

Jeffrey Riley

Synthetic Biologics

Chief Executive Officer

2017

Joseph Sliman

Synthetic Biologics

Chief Medical Officer

News

You may also like